Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Events
  • Tools
    • Members
    • Groups
    • Add/Edit Event
    • My Bookings
      • Manage Bookings
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
  • COVID-19

Oncology

Food and Drug Administration
Health / Medical / National

FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy

February 16, 2021February 16, 2021 - by MyChesCo

WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults …

Read More

HMP Global Announces Expansion into Women's Oncology
Cancer

HMP Global Announces Expansion into Women’s Oncology

November 3, 2020November 2, 2020 - by MyChesCo

MALVERN, PA — As part of its continued mission to connect the global healthcare community with clinically relevant information and education that improves patient care, HMP Global, a leading healthcare …

Read More
Galera Therapeutics
Cancer / Public Companies

Galera Therapeutics to Host Virtual KOL Event on the Treatment of Locally Advanced Pancreatic Cancer

September 23, 2020September 23, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …

Read More

Food and Drug Administration
Cancer / Government / National

FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer

July 1, 2020June 30, 2020 - by MyChesCo

WASHINGTON, D.C. — The U.S. Food and Drug Administration this week approved Keytruda (pembrolizumab) for intravenous injection for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) …

Read More
AmerisourceBergen
Cancer / Public Companies

AmerisourceBergen Selected by Deciphera Pharmaceuticals to Support QINLOCK™

June 1, 2020May 31, 2020 - by MyChesCo

VALLEY FORGE, PA — AmerisourceBergen, a global healthcare solutions leader, announced that it has been selected by Deciphera Pharmaceuticals (Deciphera) to support QINLOCK (ripretinib). AmerisourceBergen is providing a unified commercialization …

Read More

Galera Therapeutics
Cancer

Galera Therapeutics Announces Avasopasem Manganese Improved Markers of Chronic Kidney Disease in Patients Receiving Cisplatin

May 31, 2020May 31, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …

Read More
Brandywine Hospital Earns ACR Lung Cancer Screening Center Designation
Cancer / Hospitals

Brandywine Hospital Earns ACR Lung Cancer Screening Center Designation

May 15, 2020May 15, 2020 - by MyChesCo

COATESVILLE, PA — Brandywine Hospital-Tower Health has once again been designated a Lung Cancer Screening Center by the American College of Radiology (ACR) for both the hospital site in Coatesville …

Read More

Galera Therapeutics
Cancer / Products and Services / Research

Galera Therapeutics Announces New Data from the Phase 2b Trial

May 14, 2020May 14, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …

Read More
Galera Therapeutics
Cancer / Research

Galera Therapeutics Announces Presentation of Avasopasem Manganese Data at ASCO 2020 Virtual Scientific Program

May 3, 2020May 2, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …

Read More
biopharmaceutical
Cancer / Research

Galera Therapeutics Announces Avasopasem Manganese (GC4419) Maintained Anti-Cancer Benefit of Chemoradiotherapy for Head and Neck Cancer

March 1, 2020February 29, 2020 - by MyChesCo

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …

Read More

Posts navigation

1 2 Next

Most Read

  • IRS Announces All First and Second Economic Impact Payments Issued; Eligible People Can Claim Recovery Rebate Credit
  • Pennsylvania's First Vehicle Auction of 2021 to Feature 270 Vehicles for Public Purchase on February 23
  • Winter Storm Warning: More Snow and Sleet Likely Before 10pm
  • Oxford Man Found Guilty of Selling Prescription Drugs
  • Health and Human Services Announces Biden-Harris Administration Staff Appointments
  • Mother of Three Sentenced to 14 Years for Traveling to Pennsylvania to Have Sex with Teenager

Subscribe for Updates

Chester County Events

  • Academic Open House @ University of Valley Forge February 20, 2021
    • 02/20/2021
      Phoenixville
  • Beer and Bonsai at Victory Taprooms Parkesburg
    • 03/04/2021
      Parkesburg
  • SHI’s 1st Annual Spring Macrobiotic Conference (Online)
    • 03/06/2021
  • SHI’s 1st Annual Spring Macrobiotic Conference (Online)
    • 03/07/2021
  • Real World Self Defense and Law
    • 03/07/2021
      Elverson
  • all events

Follow Us

  • Facebook
  • Twitter
  • LinkedIn

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy

Recent Articles

  • ALL4 Establishes California Presence with Env Holding Corp Acquisition
  • Teleflex Completes Enrollment in CTO-PCI IDE Study
  • U.S. Department of Agriculture Announces Extension of Eviction and Foreclosure Moratoriums
  • Bridgerton Virtual Chat at Atglen Public Library
Copyright © 2021 MyChesCo.